Hybridoma producing a monoclonal antibody against Sulfatide.
Comment from the depositor
Terms and conditions
A prior written permission of the approver(Depositor) is necessary for any kind of use including academic use and for-profit use.
Remarks
approver's address
×
English
Address
Tokyo Metropolitan Institute of Medical Science Department of Molecular Medicine 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506 Japan
Dr.KAWASHIMA Ikuo
Fax. +81-3-5316-3173
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
Back
Top
CELL BANK Website